Solvonis Therapeutics (formerly Awakn) Employee Directory
Biotechnology ResearchToronto, Canada2-10 Employees
Solvonis Therapeutics plc (LSE: SVNS) is a clinical-stage biopharmaceutical company developing innovative medicines for addiction and mental health disorders. Headquartered in London and listed on the London Stock Exchange main market, Solvonis is advancing a differentiated pipeline of repurposed and novel compounds targeting high-burden neuropsychiatric conditions with significant unmet need. The company’s current focus is on Alcohol Use Disorder (AUD)—affecting over 40 million people across the U.S., UK, and EU4—and Post-Traumatic Stress Disorder (PTSD), which impacts more than 13 million adults in the U.S. and approximately 20 million across the same regions.
1-888-653-2347 
support@leadiq.com 
